導管，經皮腔內冠狀動脈成形術（PTCA），切割/劃痕
PMA 核准號：P050018 · 2025-04-04
廣告
器材摘要
Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is the device name listed in this FDA 510(k) record. The listed applicant is Spectranetics Corp.. It received FDA 510(k) clearance on 2025-04-04. The device is classified under product code NWX. It was reviewed by the CV advisory panel.
常見問題
What is the Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring?
Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is a medical device that received FDA 510(k) clearance on 2025-04-04. The listed applicant is Spectranetics Corp..
When did Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring receive FDA 510(k) clearance?
The clearance date for Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring can be found in the official FDA records.
誰是針對「心臟內腔血管成形術（PTCA）導管，切割/劃痕」所列的申請人？
The FDA 510(k) record lists Spectranetics Corp. as the applicant. This does not by itself establish the device manufacturer.
FDA產品代碼為Catheter, percutaneous transluminal coronary angioplasty (PTCA), 切割/劃痕的什麼？
FDA產品代碼對於心导管、經皮腔內冠狀動脈成形術（PTCA）、切割/劃痕為 NWX。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告